Luca Guarrera

10PUBLICATIONS
72CO-AUTHORS
Health and ecological risk assessmentRegenerative medicine (incl. stem cells)Medical devicesMolecular targetsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Nov 05, 2026
Targeting the ERO1A-PDIA1 redox axis in triple-negative breast cancer with AI-designed minibinders.

|Jun 19, 2025
Mesenchymal Stromal Cell Secretome and Its Key Bioactive Metabolites Induce Long-Term Neuroprotection After Traumatic Brain Injury in Mice.

Francesca Pischiutta, Francesca Tribuzio, Marta Magatti

|Feb 23, 2025
Increased ectodysplasin-A2-receptor EDA2R is a ubiquitous hallmark of aging and mediates parainflammatory responses.

Maria Chiara Barbera, Luca Guarrera, Andrea David Re Cecconi

|Feb 17, 2025
Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.

Ersilia Varone, Michele Retini, Alessandro Cherubini

|Aug 06, 2024
Epigenome-wide impact of MAT2A sustains the androgen-indifferent state and confers synthetic vulnerability in ERG fusion-positive prostate cancer.

Alessia Cacciatore, Dheeraj Shinde, Carola Musumeci

|Jul 22, 2024
Onvansertib treatment overcomes olaparib resistance in high-grade ovarian carcinomas.

Michela Chiappa, Alessandra Decio, Luca Guarrera

Pageof 2

Frequent Collaborators

4 joint publications

Enrico Garattini

3 joint publications

Adriana Zanetti

3 joint publications

Mami Kurosaki

3 joint publications

Mineko Terao